Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:15 PM
Ignite Modification Date:
2025-12-24 @ 4:15 PM
NCT ID:
NCT05402566
Eligibility Criteria:
Inclusion criteria:
AD-patients:
* Aged 55-85 years.
* Male or female.
* AD diagnosis by the NIA-AA 2011 research criteria.8
* Able to give written informed consent.
* Mini-mental state examination (MMSE) equal to or above 18.9
* Brain FDG-PET performed at Aarhus University Hospital consistent with AD.
Healthy participants:
* Aged 18-85 years.
* Male or female.
Exclusion criteria:
All participants:
* Diabetes or any other metabolic disease.
* Other significant brain disease:
* Strokes.
* Tumors.
* Chronic small vessel disease (clinically suspected, or Fazekas ≥ 2 if clinical MRI is available).
* Epilepsy.
* Other neurodegenerative or -inflammatory disease.
* Contraindications for MRI:
* Pacemaker, neurostimulator or cochlear implant.
* Metal foreign bodies such as fragments and irremovable piercings.
* Unsafe medical implants (safety of heart valves, hips and the like must be confirmed).
* Claustrophobia.
* Largest circumference including arms \> 160 cm.
* Pregnant - women must be post-menopausal or confirmed non-pregnant by an onsite test.
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
85 Years
Study:
NCT05402566
Study Brief:
Protocol Section:
NCT05402566